Allinky secures patent grant in China
January 24, 2025
Allinky is thrilled to announce that on December 31st, 2024, the China National Intellectual Property Administration (CNIPA) granted a patent…
U.S. Patent granted to Allinky
September 6, 2024
Allinky is proud to announce that on August 27th, 2024, the United States Patent and Trademark Office (USPTO) granted a patent for its invention…
Allinky presents its inflammation program at AseBio Investor Day in San Sebastián
May 16, 2024
AseBio Investor Day is a key event that gathers prominent figures from the biotechnology and investment communities, fostering collaboration…
Allinky is awarded a Seal of Excellence from Horizon Europe’s EIC Accelerator Program
March 11, 2024
Allinky Biopharma is thrilled to announce that it has been awarded the prestigious Seal of Excellence from the European Innovation Council (EIC)…
Allinky will attend AseBio Investor Day 2024
January 9, 2024
Allinky will attend the next edition of AseBio Investor Day , which will be held in Donostia-San Sebastian on May 15th.
AseBio Investor Day…
European patent granted to Allinky
December 20, 2023
On December 20th, 2023, the European Patent Office published the mention of the grant of the European Patent for the invention 'PYRIDIN-SULFONAMIDE…
Allinky executes a new capital increase of 2 million euros
December 2, 2023
Last December 2023, Allinky executed a new capital increase of €2 million to conclude the preclinical evaluation of its most advanced candidate,…